Independent prognostic factors for initial intravesical recurrence after laparoscopic nephroureterectomy for upper urinary tract urothelial carcinoma

Urologic Oncology: Seminars and Original Investigations

Volumn 32, Issue 2, 2014, Pages 146-152

  Liu, Yuqing ^a   Lu, Jian ^a   Hong, Kai ^a   Huang, Yi ^a   Ma, Lulin ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

Bladder cancer; Immunosuppression; Laparoscopic surgery; Recurrence; Transitional cell carcinoma

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL RECORD REVIEW; MIDDLE AGED; NEPHROURETERECTOMY; ONCOLOGICAL PARAMETERS; POSTOPERATIVE COMPLICATION; PREDICTOR VARIABLE; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RENAL GRAFT DYSFUNCTION; RETROPERITONEUM; RETROSPECTIVE STUDY; RISK FACTOR; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; TUMOR MULTIFOCALITY;

BLADDER CANCER; IMMUNOSUPPRESSION; LAPAROSCOPIC SURGERY; RECURRENCE; TRANSITIONAL CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LAPAROSCOPY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEPHRECTOMY; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; PROPORTIONAL HAZARDS MODELS; URETER; URINARY BLADDER NEOPLASMS;

EID: 84892560991     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2013.02.018     Document Type: Article

References (24)

1. Ristau B.T., Tomaszewski J.J., Ost M.C. Upper tract urothelial carcinoma: current treatment and outcomes. Urology 2012, 79:749-756.
2. Terakawa T., Miyake H., Muramaki M., Takenaka A., Hara I., Fujisawa M. Risk factors for intravesical recurrence after surgical management of the upper urinary tract. Urology 2008, 71:123-127.
3. Stevens L.A., Coresh J., Greene T., Levey A.S. Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med 2006, 354:2473-2483.
4. Li C.C., Chang T.H., Wu W.J., et al. Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients. Eur Urol 2008, 54:1127-1134.
5. Huang W.W., Huang H.Y., Liao A.C., et al. Primary urothelial carcinoma of the upper tract: important clinicopathological factors predicting bladder recurrence after surgical resection. Pathol Int 2009, 59:642-649.
6. Pieras E., Frontera G., Ruiz X., Vicens A., Ozonas M., Pizá P. Concomitant carcinoma in situ and tumour size are prognostic factors for bladder recurrence after nephroureterectomy for upper tract transitional cell carcinoma. BJU Int 2010, 106:1319-1323.
7. Ku J.H., Choi W.S., Kwak C., Kim H.H. Bladder cancer after nephroureterectomy in patients with urothelial carcinoma of the upper urinary tract. Urol Oncol 2011, 29:383-387.
8. Milojevic B., Djokic M., Sipetic-Grujicic S., et al. Bladder cancer after managing upper urinary tract transitional cell carcinoma: risk factors and survival. Int Urol Nephrol 2011, 43:729-735.
9. Kusuda Y, Miyake H, Terakawa T, Kondo Y, Miura T, Fujisawa M. Gender as a significant predictor of intravesical recurrence in patients with urothelial carcinoma of the upper urinary tract following nephroureterectomy. Urol Oncol. 10.1016/j.urolonc.2012.04.014. 2011 [in press].
10. Kim KH, You D, Jeong IG, Hong JH, Ahn H, Kim CS. Muscle-invasive bladder cancer developing after nephroureterectomy for upper urinary tract urothelial carcinoma. Urol Oncol. 10.1016/j.urolonc.2012.04.014. 2012 [in press].
11. Hirano D., Okada Y., Nagane Y., et al. Intravesical recurrence after surgical management of urothelial carcinoma of the upper urinary tract. Urol Int 2012, 89:71-77.
12. Kakizoe T. Development and progression of urothelial carcinoma. Cancer Sci 2006, 97:821-828.
13. Catto J.W., Hartmann A., Stoehr R., et al. Multifocal urothelial cancers with the mutator phenotype are of monoclonal origin and require pan-urothelial treatment for tumor clearance. J Urol 2006, 175:2323-2330.
14. Catto J.W., Yates D.R., Rehman I., et al. Behavior of urothelial carcinoma with respect to anatomical location. J Urol 2007, 177:1715-1720.
15. O'Brien T., Ray E., Singh R., Coker B., Beard R. Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicenter, randomized clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C trial). Eur Urol 2011, 60:703-710.
16. Raman J.D., Sosa R.E., Vaughan E.D., Scherr D.S. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma. Urology 2007, 69:251-254.
17. Chiang Y.J., Yang P.S., Wang H.H., et al. Urothelial cancer after renal transplantation: an update. Transplant Proc 2012, 44:744-745.
18. Buzzeo B.D., Heisey D.M., Messing E.M. Bladder cancer in renal transplant recipients. Urology 1997, 50:525-528.
19. Dietrich K., Schned A., Fortuny J., et al. Glucocorticoid therapy and risk of bladder cancer. Br J Cancer 2009, 101:1316-1320.
20. Ehdaie B., Stukenborg G.J., Theodorescu D. Renal transplant recipients and patients with end stage renal disease present with more advanced bladder cancer. J Urol 2009, 182:1482-1487.
21. Vajdic C.M., McDonald S.P., McCredie M.R., et al. Cancer incidence before and after kidney transplantation. J Am Med Assoc 2006, 296:2823-2831.
22. Miao Y., Everly J.J., Gross T.G., et al. De novo cancers arising in organ transplant recipients are associated with adverse outcomes compared with the general population. Transplantation 2009, 87:1347-1359.
23. Matsui Y., Utsunomiya N., Ichioka K., et al. Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract. Urology 2005, 65:279-283.
24. Chen G, Wang B, Li H, Ma X, Shi T, Zhang X. Applying narrow-band imaging in complement with white-light imaging cystoscopy in the detection of urothelial carcinoma of the bladder. Urol Oncol. 10.1016/jurolonc.2011.02.009. 2011 [in press].